US Stock MarketDetailed Quotes
OTLC ONCOTELIC THERAPEUTICS INC
- 0.031900
- +0.001780+5.91%
15min DelayClose Nov 29 13:00 ET
12.99MMarket Cap-3190P/E (TTM)
0.032065High0.028200Low213.98KVolume0.030250Open0.030120Pre Close6.38KTurnover0.10%Turnover RatioLossP/E (Static)407.29MShares0.04500052wk High1.45P/B7.09MFloat Cap0.01700052wk Low--Dividend TTM222.15MShs Float0.360000Historical High--Div YieldTTM12.83%Amplitude0.010000Historical Low0.029000Avg Price1Lot Size
About ONCOTELIC THERAPEUTICS INC Company
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Company Profile
SymbolOTLC
Company NameONCOTELIC THERAPEUTICS INC
Founded1988
MarketPink Market
Employees22
Fiscal Year Ends12-31
Address29397 Agoura Road,Suite 107
CityAgoura Hills
ProvinceCalifornia
CountryUnited States of America
Zip Code91301
Phone1-650-635-7000
Websitehttp://www.oncotelic.com
Company Executives
- Name
- Position
- Salary
- Vuong Trieu
- Chairman of the Board and Chief Executive Officer
- --
- Saran Saund
- Chief Business Officer
- --
- Anthony E. Maida III
- Director and Chief Medical Officer (Consultant)
- --
- Amit Shah
- Chief Financial Officer
- --
- Steven W. King
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data